wp-block-group

Gregory Laurence, MD

For more than three decades, Gregory Laurence, MD has pursued a forward-thinking approach to medicine centered around recovery, longevity, cellular science, and highly personalized patient care.

Over the last nine years, Dr. Laurence has focused extensively on regenerative medicine technologies, physician-led cellular therapies, and longer-term regenerative care strategies. His work centers on disciplined, evidence-informed regenerative medicine designed to help patients pursue recovery, mobility, healthier aging, and long-term quality of life.

Dr. Laurence believes regenerative medicine should be approached thoughtfully, transparently, and with rigorous physician oversight rather than hype or transactional treatment models. That philosophy continues to direct the trajectory of SYLF™ Regenerative Medicine.

As a respected leader in the field, Dr. Laurence is committed to participating in regenerative medicine education, physician training, and industry leadership initiatives











His expertise in regenerative medicine and dedication to patient advocacy both contribute to, and help shape, broader conversations surrounding the future of personalized healthcare and regenerative medicine.

Tennessee law stands at the forefront of progress in regenerative medicine. Dr. Laurence, and SYLF™, actively support Tennessee’s regenerative medicine legislation (HB 2246) as a positive step that expands patient access while establishing meaningful guardrails around sourcing, informed consent, and advertising transparency. He serves as an engaged member of the Tennessee Medical Association (TMA) and previously served as Representative for District 1 on the TMA Political Action Committee from 2020 to 2024, contributing to legislative efforts and policy discussions that support Tennessee physicians and patients.

His involvement in regenerative medicine advocacy, physician education, and clinical leadership reflects the broader mission behind SYLF™: advancing disciplined, physician-led regenerative medicine focused on long-term patient outcomes and responsible innovation.